AI Article Synopsis
- mRNA vaccines, like those from Moderna and BioNTech/Pfizer, have played a crucial role in managing COVID-19, allowing a gradual shift away from strict social distancing and lockdowns.
- This technology has gained significant public attention and research focus, opening the door for innovation in bionanotechnology.
- Beyond COVID-19, mRNA vaccines hold promise for long-term solutions for various diseases, including influenza and AIDS, with ongoing studies exploring their future applications.
Article Abstract
mRNA vaccines have received major attention in the fight against COVID-19. Formulations from companies such as Moderna and BioNTech/Pfizer have allowed us to slowly ease the social distancing measures, mask requirements, and lockdowns that have been prevalent since early 2020. This past year's focused work on mRNA vaccines has catapulted this technology to the forefront of public awareness and additional research pursuits, thus leading to new potential for bionanotechnology principles to help drive further innovation using mRNA. In addition to alleviating the burden of COVID-19, mRNA vaccines could potentially provide long-term solutions all over the world for diseases ranging from influenza to AIDS. Herein, we provide a brief commentary based on the history and development of mRNA vaccines in the context of the COVID-19 pandemic. Furthermore, we address current research using the technology and future directions of mRNA vaccine research.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8502079 | PMC |
| http://dx.doi.org/10.1016/j.addr.2021.114000 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!